Skip to main content
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Cited by
    This chapter has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Patiño-García, Daniel Cruz-Fernandes, Leonor Buñay, Julio Palomino, Jaime and Moreno, Ricardo D 2018. Reproductive Alterations in Chronically Exposed Female Mice to Environmentally Relevant Doses of a Mixture of Phthalates and Alkylphenols. Endocrinology, Vol. 159, Issue. 2, p. 1050.

  • Print publication year: 2011
  • Online publication date: February 2011

Chapter 10 - Molecular aspects of follicular development

from Section 3 - Reproductive biology and cryobiology
Cancer is more common after puberty during the reproductive life span of men and women, and many of the patients will be cured by combination treatment with surgery, chemotherapy and radiotherapy. The model of human ovarian reserve allows us to estimate the number of non-growing follicles (NGFs) present in the ovary at any given age, and it suggests that 81% of the variance in NGF populations is due to age alone. The ovary is susceptible to chemotherapy-induced damage, particularly following treatment with alkylating agents such as cyclophosphamide. Ovarian damage is drug- and dose-dependent and is related to age at the time of treatment, with progressively smaller doses required to produce ovarian failure with increasing age. Preventing chemotherapy-induced damage to the ovary or testes remains an elusive ideal in the field of fertility preservation. Both chemotherapy and radiotherapy can impair future fertility, and treatments for certain cancers can be sterilizing.
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Principles and Practice of Fertility Preservation
  • Online ISBN: 9780511921896
  • Book DOI:
Please enter your name
Please enter a valid email address
Who would you like to send this to *


1. ByskovAG. Differentiation of mammalian embryonic gonad. Physiol Rev 1986; 66: 71–117.
2. FaddyMJ, GosdenRG, GougeonA, RichardsonSJ and NelsonJF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992; 7: 1342–6.
3. GondosB, WestergaardL and ByskovAG. Initiation of oogenesis in the human fetal ovary: ultrastructural and squash preparation study. Am J of Obstet Gynecol 1986; 155(1): 189–95.
4. Lintern-MooreS and MooreGP. The initiation of follicle and oocyte growth in the mouse ovary. Biol Reprod 1979; 20: 773–8.
5. SkinnerMK. Regulation of primordial assembly and development. Hum Reprod Update 2005; 11(5): 461–71.
6. AlbertiniDF, CombellesCM, BenecchiE and CarabatsosMJ. Cellular basis for paracrine regulation of ovarian follicle development. Reproduction 2001; 121: 647–53.
7. JohnsonMH. Johnson and Everitt's Essential Reproduction, 6th edn. Oxford: Blackwell Publishing, 2007: pp. 82–91.
8. TelferEE and McLaughlinM. Natural History of the mammalian oocyte. Reprod Biomed Online 2007; 15: 288–95.
9. EppigJJ. Oocyte control of ovarian follicular development and function in mammals. Reproduction 2001; 122: 829–38.
10. McNattyKP, MooreLG, HudsonNLet al. The oocyte and its role in regulating ovulation rate: a new paradigm in reproductive biology. Reproduction 2004; 128: 379–86.
11. GilchristRB and ThompsonJG. Oocyte maturation: emerging concepts and technologies to improve developmental potential in vitro. Theriogenology 2007; 67: 6–15.
12. MehlmannLM. Stops and stars in mammalian oocytes: recent advances in understanding the regulation of meiotic arrest and oocyte maturation. Reproduction 2005; 130: 791–9.
13. HuntPA and HassoldTJ. Human female meiosis: what makes a good egg go bad?TIG 2008; 24(2): 86–93.
14. TatoneC, AmicarelliF, CarboneM Cet al. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update 2008; 14(2): 131–42.
15. HongSJ, ChiuP, LeeKFet al. Cumulus cells and their extracellular matrix affect the quality of the spermatozoa penetrating the cumulus mass. Fertil Steril 2009; 92(3): 971–8.
16. ChungMK, ChiuPCN, LeeCLet al. Cumulus-associated alpha2-macroglobulin derivative retains pro-conceptive glycodelin-C in the human cumulus matrix. Hum Reprod 2009; 24(11): 2856–67.
17. MaheshwariA and FowlerPA. Primordial follicular assembly in humans- revisited. Zygote 2008; 16: 285–96.
18. OhnoS, KlingerHP and AtkinNB. Human oogenesis. Cytogenetics 1962; 1: 42–51.
19. BowlesJ and KoopmanP. Retinoic acid, meiosis and germ cell fate in mammals. Development 2007; 134: 3401–11.
20. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940–54.
21. KezeleP and SkinnerMK. Regulation of ovarian primordial follicle assembly and development by oestrogen and progesterone: endocrine model of follicle assembly. Endocrinology 2003; 144: 3329–37.
22. TingenC, KimA and WoodruffTK. The primordial pool of follicles and nest breakdown in mammalian ovaries. Mol Hum Reprod 2009; 15(12): 795–803.
23. FairT, HulshofSCJ, HyttelP, BolandM and GreveT. Bovine oocyte ultrastructure in primordial to tertiary follicles. Anat Embryol 1997; 195: 327–36.
24. ParrottJA and SkinnerMK. Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis. Endocrinology 1999; 140: 4262–71.
25. NilssonEE and SkinnerMK. Bone morphogenetic protein-4 acts as an ovarian follicle survival factor and promotes primordial follicle development. Biol Reprod 2003; 69: 1265–72.
26. AdhikariD and LiuK. Molecular mechanisms underlying the activation of mammalian primordial follicles. Endocr Rev 2009; 30: 438–64.
27. LiuK, RajareddyS, LiuLet al. Control of mammalian oocyte growth and early follicular development by the oocyte PI3 kinase pathway: old timer. Dev Biol 2006; 299: 1–11.
28. LiuK. Stem cell factor (SCF)-kit mediated phosphatidylinositol-3 (PI3) kinase signalling during mammalian oocyte growth and early follicular development. Front Biosci 2006; 11: 126–35.
29. NagaoS, MuraoK, ImachiHet al. Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells. FEBS Lett 2006; 580: 4371–6.
30. PinkasH, FischB, RozanskyGet al. Platelet-derived growth factors (PDGF-A and -B) and their receptors in human fetal and adult ovaries. Mol Hum Reprod 2008; 14(4): 199–206.
31. NilssonE and SkinnerMK. Cellular interactions that control primordial follicle development and folliculogenesis. J Soc Gynecol Investig 2001; 8: S17–20.
32. GospodarowiczD, PlouetJ and FujiiDK. Ovarian germinal epithelial cells respond to basic fibroblast growth factor and express its gene: implications for early folliculogenesis. Endocrinology 1989; 125: 1266–76.
33. LavranosTC, RodgersHF, BartoncelloI and RodgersRJ. Anchorage independent culture of bovine granulosa cells: the effects of basic fibroblast growth factor and Dibutyryl cAMP on cell division and differentiation. Exp Cell Res 1994; 211: 245–51.
34. VernonRK and SpicerLJ. Effects of basic fibroblast growth factor and heparin on follicle stimulating hormone induced steroidogenesis by bovine granulosa cells. J Anim Sci 1994; 72: 2696–702.
35. AndersonE and LeeGY. The participation of growth factors in simulating the quiescent, proliferative, and differentiative stages of rat granulosa cells grown in serum free medium. Tissue Cell 1993; 25: 49–72.
36. TillyJL, BilligH, KowalskiKI and HsuehAJ. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase dependent mechanism. Mol Endocrinol 1992; 6: 1942–50.
37. GadientRA and PattersonPH. Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells 1999; 17: 127–37.
38. NilssonE and SkinnerMK. Growth and differentiation factor-9 stimulates progression of early primary but not primordial rat ovarian follicle development. Biol Reprod 2002; 67: 1018–24.
39. LeeWS, OstukaF, MooreRK and ShimasakiS. Effect of bone morphogenetic protein-7 on folliculogenesis in the rat. Biol Reprod 2001; 65: 994–9.
40. LeeWS, YoonSJ, YoonTKet al. Effects of bone morphogenetic protein-7 (BMP-7) on primordial follicular growth in the mouse ovary. Mol Reprod Dev 2004; 69: 159–63.
41. VisserJA and ThemmenAP. Anti-Müllerian hormone and folliculogenesis. Mol Cell Endocrinol 2005; 234: 81–6.
42. AdhikariD, FlohrG, GorreNet al. Disruption of Tsc2 in oocyte leads to over-activation of the entire pool of primordial follicles. Mol Hum Reprod 2009; 15 (12): 765–70.
43. Chong-KoperaH, InokiK, LiYet al. TSC1 stabilises TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J Biol Chem 2006; 281: 8313–16.
44. CastrillonDH, MiaoL, KolliparaR, HornerJW and DePinhoRA. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 2003; 301: 215–18.
45. ReddyP, LiuL, AdhikariDet al. Oocyte specific deletion of Pten causes premature activation of the primordial follicle pool. Science 2008; 319: 611–13.
46. JohnGB, GallardoTD, ShirleyLJ and CastrillonDH. Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth. Dev Biol 2008; 321: 197–204.
47. CrisponiL, DeianaM, LoiAet al. The putative fork-head transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nature Genet 2001; 27: 159–66.
48. DuffinK, BayneRAL, ChildsAJ, CollinsC and AndersonRA. The forkhead transcription factor FOXL2 is expressed in somatic cells of the human ovary prior to follicle formation. Mol Hum Reprod 2009; 15(12): 771–7.
49. UdaM, OttolenghiC, CrisponiLet al. Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Gen 2004; 13: 1171–81.
50. SchmidtD, OvittCE, AnlagKet al. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 2004; 131: 933–42.
51. HillierSG. Paracrine support of ovarian stimulation. Mol Hum Reprod 2009; 15(12): 843–50.
52. HillierSG. Regulatory functions for inhibin and activin in human ovaries. J Endocrinol 1991; 131: 171–5.
53. LavenJS, Von BerghAR, CranfieldMet al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004; 10(2): 77–83.
54. XuJ, OakleyJ and McGeeEA. Stage-specific expression of Smad2 and Smad3 during folliculogenesis. Biol Reprod 2002; 66: 1571–8.
55. TomicD, MillerKP, KennyHAet al. Ovarian follicle development requires Smad3. Mol Endocrinol 2004; 18: 2224–40.
56. NilssonE, RogersN and SkinnerMK. Actions of anti-Müllerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction 2007; 134: 209–21.
57. GilchristRB, LaneM and ThompsonJG. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update 2008; 14(2): 159–77.
58. DongJ, AlbertiniDF, NishimoriKet al. Growth differentiation factor 9 is required during early ovarian folliculogenesis. Nature 1996; 383: 531–5.
59. GallowaySM, McNattyKP, CambridgeLMet al. Mutations in an oocyte-derived growth factor gene (BMP15) caused increased ovulation rate and infertility in a dosage sensitive manner. Nature Genet 2000; 25: 279–83.
60. KnightPG and GlisterC. Focus on TGF-β signalling: TGF-β superfamily members and ovarian follicle development. Reproduction 2006; 132: 191–206.
61. EppigJJ. Intercommunication between mammalian oocytes and companionsomatic cells. Bioessays 1991; 13: 569–74.
62. SimonAM, GoodenoughDA, LiE and PaulDL. Female infertility in mice lacking connexin37. Nature 1997; 385: 525–9.
63. FairT. Mammalian oocyte development: checkpoints for competence. Reprod Fertil Dev 2010; 22: 13–20.
64. KwintkiewiczJ and GiudiceLC. The interplay of insulin-like growth factors, gonadotrophins, and endocrine disruptors in ovarian follicular development and function. Semin Reprod Med 2009; 27(1): 43–51.
65. SchneyerAL, FujiwaraT, FoxJet al. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations. J Clin Endocrinol Metab 2000; 85: 3319–30.
66. HillierSG, PurohitA and ReichertLE Jr. Control of granulosa cell lactate production by follicle stimulating hormone and androgen. Endocrinology 1985; 116: 1163–7.
67. BachvarovaR. Gene expression during oogenesis and oocyte development in mammals. Dev Biol (NY) 1985; 1: 453–524.
68. TapanainenJS, VaskivuoT, AittomakiK and HuhtaniemiIT. Inactivating FSH receptor mutations and gonadal dysfunction. Mol Cell Endocrinol 1998; 145: 129–35.
69. CombellesCM, CarabatsosMJ, KumarTR, MatzukMM and AlbertiniDF. Hormonal control of somatic cell oocyte interactions during ovarian follicle development. Mol Reprod Dev 2004; 69: 347–55.
70. ChianRC, LimJH and TanSL. State of the art in vitro oocyte maturation. Curr Opin Obstet Gynecol 2004; 16: 211–19.
71. TangheS, SoomAV, NauwynckH, MarcC and De Kruif. A. Mini review: functions of the cumulus oophorus during oocyte maturation, ovulation and fertilisation. Mol Reprod Dev 2002; 61: 414–24.
72. ZeleznikAJ and HillierSG. The role of gonadotrophins in the selection of the pre-ovulatory follicle. Clin Obstet Gynecol 1984; 27: 927–40.
73. HillierSG. Current concepts of the roles of follicle stimulating hormone and luteinising hormone in folliculogenesis. Hum Reprod 1994; 9: 188–91.
74. PengXR, HsuehAJ, LaPoltPS, BjersingL and NyT. Localization of luteinizing hormone receptor messenger ribonucleic acid expression in ovarian cell types during follicle development and ovulation. Endocrinology 1991; 129: 3200–7.
75. EppigJJ, ChesnelF, HiraoYet al. Oocyte control of granulosa cell development: how and why. Hum Reprod 1997; 12: 127–32.
76. JonesKT. Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age. Hum Reprod Update 2008; 14(2): 143–58.
77. RussellDL and RobkerRL. Molecular mechanisms of ovulation: co-ordination through the cumulus complex. Hum Reprod Update 2007; 13: 289–312.
78. KryskoDV, Diez-FraileA, CrielGet al. Life and death of female gametes during oogenesis and folliculogenesis. Apoptosis 2008; 13(9): 1065–87.
79. BoyerA, GoffAK and BoerboomD. WNT signalling in ovarian follicle biology and tumorigenesis. Trends Endocrinol Metab 2009; 21(1): 25–32.
80. ParakhTN, HernandezJA, GrammerJCet al. Follicle-stimulating hormone/cAMP regulation of aromatase gene expression requires beta-catenin. Proc Natl Acad Sci USA 2006; 103(33): 12435–40.
81. WangH, TekpeteyFR and KidderGM. Identification of WNT/β-CATENIN signalling pathway components of human cumulus cells. Mol Hum Reprod 2009; 15(1): 11–17.
82. SenaP, RiccioM, MarzonaLet al. Human MATER localisation in specific cell domains of oocytes and follicular cells. Reprod Biomed Online 2009; 18(2): 226–34.
83. TongZB, BondyCA, ZhouJ and NelsonLM. A human homologue of mouse MATER, a maternal effect gene essential for early embryo development. Hum Reprod 2002; 17: 903–11.
84. MaraldiT, RiccioM, SenaPet al. MATER protein as substrate of PKCepsilon in human cumulus cells. Mol Hum Reprod 2009; 15(8): 499–506.
85. AssouS, HaouziD, MahmoudKet al. A non-invasive test for assessing embryo potential by gene expression profiles of human cumulus cells: a proof of concept study. Mol Hum Reprod 2008; 14(12): 711–19.
86. LiQ, McKenzieLJ and MatzukMM. Revisiting oocyte-somatic cell interactions: in search of novel intrafollicular predictors and regulators of oocyte developmental competence. Mol Hum Reprod 2008; 14: 673–8.
87. LiQ, RajanahallyS, EdsonMA and MatzukMM. Stable expression and characterization of N-terminal tagged recombinant human bone morphogenetic protein 15. Mol Hum Reprod 2009; 15(12): 779–88.
88. EppigJJ and DownSM. Chemical signals that regulate mammalian oocyte maturation. Biol Reprod 1984; 30: 1–11.
89. MehlmannLM, SaekiY, TanakaSet al. The Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes. Science 2004; 306: 1947–50.
90. DuncanFE, MossSB and WilliamsCJ. Knockdown of the cAMP-dependent protein kinase (PKA) type Iα regulatory subunit in mouse oocytes disrupts meiotic arrest and results in meiotic spindle defects. Dev Dyn 2006; 235: 2961–8.
91. EppigJJ, VivierosMM, Marin-BivensC and De La FuenteR. Regulation of mammalian oocyte maturation. In: Leung PCK and Adashi EY (eds.), The Ovary. Amsterdam: Elsevier Academic Press, 2004: pp. 113–29.
92. DownsSM and Hunzicker-DunnM. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site selective analogues of cyclic adenosine phosphate. Dev Biol 1995; 172: 72–85.
93. ShimadaM, NishiboriM, IsobeN and TeradaT. Luteinising hormone receptor formation in cumulus cells surrounding porcine oocytes and its role during meiotic maturation of porcine oocytes. Biol Reprod 2003; 68: 1142–9.
94. ZhangM, OuyangH and XiaG. The signal pathway of gonadotrophins-induced mammalian oocyte meiotic resumption. Mol Hum Reprod 2009; 15: 399–409.
95. Sela-AbramovichS, ChorevE, GalianiD and DekelN. Mitogen-activated protein kinase mediates luteinising hormone-induced breakdown of communication and oocyte maturation in rat ovarian follicles. Endocrinology 2005; 146: 1236–44.
96. DekelN. Regulation of oocyte maturation. The role of cAMP. Ann NY Acad Sci 1988; 541: 211–16.
97. FagbohunCF and DownsSM. Metabolic coupling and ligand stimulated meiotic maturation in the mouse oocyte-cumulus cell complex. Biol Reprod 1991; 45: 851–9.
98. ContiM. Phosphodiesterases and cyclic nucleotide signalling in endocrine cells. Mol Endocrinol 2000; 14: 1317–27.
99. ContiM, HsiehM, ParkJY and SuYQ. Role of the epidermal growth factor network in ovarian follicles. Mol Endocrinol 2006; 20: 715–23.
100. DiazFJ, O’BrienMJ, WigglesworthK and EppigJJ. The pre-granulosa cell to cumulus cell transition in the mouse ovary: development of competence to undergo expansion. Dev Biol 2006; 299: 91–104.
101. ElvinJA, ClarkAT, WangP, WolfmanNM and MatzukMM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 1999; 13: 1035–48.
102. ChangH, BrownCW and MatzukMM. Genetic analyses of the mammalian transforming growth factor beta superfamily. Endocr Rev 2002; 23: 787–823.
103. VanderhydenBC, MacdonaldEA, NagyovaE and DhawanA. Evaluation of members of the TGFβ superfamily for the oocyte factors that control mouse cumulus expansion and steroidogenesis. Reproduction Supplement 2003; 61: 55–70.
104. DixitVD and ParviziN. Nitric oxide and the control of reproduction. Anim Reprod Sci 2001; 65: 1–16.
105. YamagataY, NakarmuraY, SuginoNet al. Alterations in nitrate/nitrite and nitric oxide synthase in preovulatory follicles in gonadotrophin-primed immature rat. Endocr J 2002; 49: 219–26.
106. ParkJY, SuYQ, ArigaMet al. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 2004; 303: 682–4.
107. HsiehM, ZamahAM and ContiM. Epidermal growth factor-like growth factors in the follicular fluid: role in oocyte development and maturation. Semin Reprod Med 2009; 27 (1): 52–61.
108. ByskovAG, AndersenCY, NordholmLet al. Chemical structure of sterols that activate oocyte meiosis. Nature 1995; 374: 559–62.
109. ByskovAG, AndersenCY and LeonardsenL. Role of meiosis activating sterols, MAS, in induced oocyte maturation. Mol Cellular Biol 2002; 187: 189–96.
110. GrondahlC, OttesenJL, LesslMet al. Meiosis-activating sterol promotes resumption of meiosis in mouse oocytes cultured in vitro in contrast to related oxysterols. Biol Reprod 1998; 58: 1297–1302.
111. GrondahlC, HansenTH, Marky-NielsenK, OttesenJL and HyttelP. Human oocyte maturation in vitro is stimulated by meiosis-activating sterol. Hum Reprod 2000; 15 (Suppl 5): 3–10.
112. Hegele-HartungC, GrutznerM, LesslMet al. Activation of meiotic maturation in rat oocytes after treatment with follicular fluid meiosis-activating sterol in vitro and ex-vivo. Biol Reprod 2001; 64: 418–24.
113. Hegele-HartungC, KuhnkJ, LesslMet al. Nuclear and cytoplasmic maturation of mouse oocytes after treatment with follicular fluid meiosis-activating sterol in vitro. Biol Reprod 1999; 61: 1362–72.
114. CukurcamS, Hegele-HartungC and Eichenlaub RitterU. Meiosis-activating sterol protects oocytes from precocious chromosome segregation. Hum Reprod 2003; 18: 1908–17.
115. Marin BivensCL, GrondahlC, MurrayAet al. Meiosis-activating sterol promotes the metaphase I to metaphase II transition and preimplantation developmental competence of mouse oocytes maturing in vitro. Biol Reprod 2004; 70: 1458–64.
116. ChianRC, AoA, ClarkeHJ, TulandiT and TanSL. Production of steroids from human cumulus cells treated with different concentrations of gonadotropins during culture in vitro. Fertil Steril 1999; 71(1): 61–6.
117. ShimadaM and TeradaT. FSH and LH induce progesterone production and progesterone receptor synthesis in cumulus cells: a requirement for meiotic resumption in porcine oocytes. Mol Hum Reprod 2002; 8: 612–18.
118. YamashitaY, NishiboriM, TeradaT, IsobeN and ShimadaM. Gonadotrophin-induced delta 14-reductase and delta 7-reductase gene expression in cumulus cells during meiotic resumption of porcine oocytes. Endocrinology 2005; 146: 186–94.
119. NingG, OuyangH, WangSet al. CREB up-regulated CYP-51 expression involved in FSH induced mouse oocyte maturation. Mol Endocrinol 2008; 22: 1682–94.
120. ShimadaM and TeradaT. Roles of cAMP in regulation of both MAP kinase and p34cdc32 kinase activity during meiotic progression, especially beyond the MI stage. Mol Reprod Dev 2002; 62: 124–31
121. JamnongjitM, GillA and HammesSR. Epidermal growth factor receptor signalling is required for normal ovarian steroidogenesis and oocyte maturation. Proc Natl Acad Sci USA 2005; 102: 16257–62.
122. TsafririA and MotolaS. Are steroids dispensable for meiotic resumption in mammals?Trends Endocrinol Metab 2007; 18(8): 321–6.
123. SagataN, WatanabeN, Vande WoudeGF and IkawaY. The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature 1989; 342: 512–18.
124. KaplanG, AbreuSL and BachvarovaR. rRNA accumulation and protein synthetic patterns in growing mouse oocytes. J Exp Zool 1982; 220: 361–70.
125. Eichenlaub-RitterU and PeschkeM. Expression in in-vivo and in-vitro growing and maturing oocytes: focus on regulation of expression at the translational level. Hum Reprod Update 2002; 8: 21–41.
126. HsiehM, LeeD, PanigoneSet al. Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation. Mol Cell Biol 2007; 27: 1914–24.
127. RichardsJS, LiuZ and ShimadaM. Immune-like mechanisms in ovulation. Trends Endocrinol Metab 2009; 19(6): 191–6.
128. ReizelY, ElbazJ and DekelN. Sustained activity of the EGF receptor is an absolute requisite for LH-induced oocyte maturation and cumulus expansion. Mol Endocrinol 2010; 24(2): 402–11.
129. RobkerRL and RichardsJS. Hormonal control of the cell cycle in ovarian cells: proliferation versus differentiation. Biol Reprod 1998; 59: 476–82.
130. FanH, LiuZ, CahillN and RichardsJS. Targeted disruption of PTEN in ovarian granulosa cells enhances ovulation and extends the life span of luteal cells. Mol Endocrinol 2008; 22(9): 2128–40.